GANZONI & CIE AG – Trademark Portfolio
Entity Type: 03
GANZONI & CIE AG holds 34 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 33 filings in this category. The portfolio also extends into Class 25 (Clothing) across 6 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SIGVARIS. The owner is based in CH-9014 ST. GALLEN.
GROEBLISTRASSE 8
CH-9014 ST. GALLEN , CH
Showing of trademarks Trademarks
Trademark Classifications
GANZONI & CIE AG's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does GANZONI & CIE AG have?
GANZONI & CIE AG has 34 U.S. trademarks filed with the USPTO. Of these, 2 registered, 6 abandoned, 21 cancelled.
What trademark classes does GANZONI & CIE AG file in?
GANZONI & CIE AG files trademarks across 6 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 25 (Clothing), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 1 (Chemicals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are GANZONI & CIE AG's most well-known trademarks?
GANZONI & CIE AG's registered trademark portfolio includes well-known marks such as SIGVARIS. These are among 2 currently registered trademarks in the portfolio.
What is GANZONI & CIE AG's trademark registration success rate?
GANZONI & CIE AG has a 7% trademark registration rate, with 2 out of 29 resolved applications resulting in successful registration. Currently, 0 applications are pending review.